Editorial Board Member

Klaus Pors

Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, West Yorkshire, UK

HomePage

https://www.bradford.ac.uk/staff/kpors1

Research Interests

cytochrome, prostate cancer, drug discovery, target oriented synthesis, medicinal chemistry, diversity-oriented synthesis, small molecules, pharmacoepigenetics, molecular fluorescent probes

Contributions:

Androgen-AR axis in primary and metastatic prostate cancer: chasing steroidogenic enzymes for therapeutic intervention

Current challenges and opportunities in treating hypoxic prostate tumors

Expression and regulation of aldehyde dehydrogenases in prostate cancer

Introduction of the special issue “How does the prostate cancer microenvironment affect the metastatic process and/or treatment outcome?”

Special Issue:

How does the prostate cancer microenvironment affect the metastatic process and/or treatment outcome?

Submit a Manuscript

Manuscript Templates

Aims and Scope